New study aims to reduce side effects of skin cancer drug
NCT ID NCT03610022
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study looked at 27 patients with advanced basal cell carcinoma who were taking the drug vismodegib. The goal was to see if the amount of drug in the blood is linked to side effects like muscle cramps, hair loss, and taste changes. By understanding this link, doctors hope to adjust doses to reduce side effects while keeping the treatment effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BASAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chu de Bordeaux
Bordeaux, France
Conditions
Explore the condition pages connected to this study.